Researchers reveal that GLP-1 medication Ozempic may reduce biological age, offering new hope in the fight against aging and related health issues.
A group of researchers claim that Ozempic may reduce the user’s biologic age by just over three years, according to a 32-week, double-blind, placebo-controlled trial by TruDiagnostic.
Ozempic may reduce biological age, offering new hope in the fight against aging and related health issues.
Author summary: Ozempic reduces biological age by three years.